AH Bio Fund II, L.P. bought $5M of SCTX stock

AH Bio Fund II, L.P., 10% owner of Scribe Therapeutics, Inc. (SCTX), bought 333,333 shares of SCTX stock worth $5M, per an SEC Form 4 filed Jul 29, 2026.

It was an open-market purchase.

The trade happened on Jul 27, 2026, 2 days before it was made public.

SCTX has moved -13.8% since the trade date, from $18.97 to $16.36 (Nov 13, 2026 close).